Ever wondered what's really happening behind the scenes in the biotech and pharmaceutical industry? Drug Dealin' pulls back the curtain. Co-hosts Shivu Sharma and Kenny Lalwani, two seasoned BioPharma professionals, offer unparalleled insider insights, dissecting the latest news, trends, and catalysts. Each episode features in-depth discussions and interviews with industry luminaries, giving you honest and unvarnished perspectives you won't find anywhere else.
SUMMARY
In this episode, Shivu and Kenny discuss how you as a caregiver or patient can use public resources like clinicaltrials.gov (http://clinicaltrials.gov) and Large Language Models (LLMs) like ChatGPT to discover the latest treatment options for a particular disease and empower yourself to have a more productive conversation with your doctor. Kenny and Shivu discuss an example of this situation from an episode of Apple TV's "Shrinking", starring Harrison Ford. In the episode they go through a demo of how they would find new treatment options for Ford's character, a patient suffering from Parkinson's Disease who has exhausted all available treatment options.
CHAPTERS
00:00 Introduction to Clinical Trials
03:04 The Importance of Patient Involvement
06:13 Navigating Clinical Trials: A Practical Guide
09:06 Using AI to Enhance Patient Care
11:53 Drafting Effective Communication with Doctors
14:27 Empowering Patients Through Knowledge
17:46 Finding the Right Treatment Options
20:30 The Role of Research in Patient Advocacy
23:03 Conclusion and Future Directions
34:38 Outro
Questions? Email us at: mailto:drugdealinpod@gmail.com (mailto:drugdealinpod@gmail.com)
Follow Shivu on X(@bigpharmasharma): https://x.com/BigPharmaSharma (https://x.com/BigPharmaSharma)
Sign up for Shivu's newsletter: https://www.bigpharmasharma.com/ (https://www.bigpharmasharma.com/)
Follow Kenny on Linkedin: (https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqbFRpZFJubWFFTDZmZ3pjMkxFbHd3SDVUcldVd3xBQ3Jtc0tuOVZHVkh5N0xhdVotYnRMRUdiUHZJNl9ia2ZVM29wUW1JUE5tbmZRWXMwMUxmUFB0Mlh2Sm1JcjJ4dU56TUxGbjF4X2M4c2tnMlEyNTMtT1NTMWtUamFCVnVKV0ZkR1RiRkpYalkzb1dpeWZ4azNuWQ&q=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fkennylalwani&v=BWLdXCsWrdQ)https://www.linkedin.com/in/kennylalwani/ (https://www.linkedin.com/in/kennylalwani/)
DISCLAIMER: The views and opinions expressed in this podcast are for informational and educational purposes only. They are not intended as medical advice and should not be used as a substitute for professional medical judgment or guidance. Always consult a qualified healthcare provider with any questions you may have regarding a medical condition or treatment.
29 Jan 2026
Ep. 8: 2026 Predictions
Summary
In this episode, Shivu and Kenny review their predictions for 2025 and make new predictions for 2026. They discuss trends in mergers and acquisitions, market performance, the impact of AI in drug development, and the rise of digital advertising in the pharmaceutical industry. They also explore the evolving landscape of biotech companies, regulatory changes from the FDA, and the growing interest in metabolic diseases and psychedelics. Finally, they introduce the 'pharm to table' model in pharma, emphasizing direct-to-patient commercial channels and how these increase patient agency.
Chapters
00:00 Introduction and Overview of Predictions
04:37 Grading 2025 Predictions
10:35 Shivu's 2025 Predictions and Grades
16:53 2026 Predictions: Emerging Trends
22:50 Regulatory Landscape and the FDA's Role
30:46 Predictability in Drug Approval Processes
30:51 The Metabolic Space and GLP-1s
33:08 Big Pharma's Entry into Obesity and Diabetes
34:56 The Risk of Commoditization in Drug Markets
37:06 Differentiation in the GLP-1 Market
39:40 The Rise of Psychedelics in Psychiatry
47:21 Pharm-to-Table Model in Pharma
54:06 Empowering Patients through Direct Access
Questions? Emal us at: drugdealinpod@gmail.com (mailto:drugdealinpod@gmail.com)
Follow Shivu on X: @bigpharmasharma (https://x.com/BigPharmaSharma)
Sign up for Shivu's newsletter: Big Pharma Sharma (https://www.bigpharmasharma.com/)
Follow Kenny on Linkedin (https://www.linkedin.com/in/kennylalwani)
DISCLAIMER: The views and opinions expressed in this podcast are for informational and educational purposes only. They are not intended as medical advice and should not be used as a substitute for professional medical judgment or guidance. Always consult a qualified healthcare provider with any questions you may have regarding a medical condition or treatment.
20 Nov 2025
Ep.7: Biotech M&A Insights: CVRs, Patent Cliffs & The Pfizer-Novo Bidding War
Hosts Shivu and Kenny Lalwani analyze biopharma M&A trends, dissecting the Pfizer-Novo bidding war and the increasing use of Contingent Value Rights to mitigate risks, offering insights into portfolio diversification strategies in this interview.
9 Sept 2025
Ep. 6: Should the FDA Be Independent?
Shivu and Kenny explore the critical question of whether the FDA should operate independently, examining its impact on drug approvals and patient care.
1 Jul 2025
Ep. 5: How to Talk to Doctors | Feat. Joe McCann, Co-Founder/CEO of Slingshot Insights
Joe McCann, CEO of Slingshot Insights, shares his expertise on preparing for and conducting effective conversations with doctors, offering insights applicable to both industry professionals and individuals seeking better healthcare in this interview.
19 May 2025
Ep.4: Ozempic for the Brain, A New Era to Explain
Host Shivu Sharma and Host Kenny Lalwani explore GLP-1 drugs' expanding potential beyond diabetes, discussing CNS applications and future healthcare impacts in this interview.
11 Mar 2025
Ep 3: Rise of the Phoenix | Sujal Shah & CymaBay Therapeutics
Biotech leader Sujal Shah, former CEO of CymaBay Therapeutics, shares his journey of resilience and leadership in building a company through adversity in this interview.
31 Jan 2025
Ep. 2: Predictions for Biopharma in 2025
Host Kenny and guest Shivu, biopharma experts, share their top three predictions for the industry's future in 2025.
31 Jan 2025
Ep. 1: Do Pharma Companies Avoid Cures?
Host [Host Name] interviews [Guest Name, Credential] to explore why pharmaceutical companies may not prioritize curative therapies despite public perception.
30 Jan 2025
Ep. 0: Welcome to the Drug Dealin' Podcast!
Hosts [Host Name] and [Co-host Name] introduce the "Drug Dealin'" podcast, outlining its content and purpose for listeners.
Who has been a guest on Drug Dealin
Names identified in recent episode analyses. Showing up to five guests.
Joe McCann
Sujal Shah
[Guest Name Credential]
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
468
Score snapshot 15 Sept 2025
Apple Podcasts (US)
5.0 / 5
7 ratings
Spotify
5.0 / 5
7 ratings
Podcast Authority Score: 38 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
30
Social presence
0
YouTube
66
Engagement
51
Contact Drug Dealin
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Drug Dealin?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
